ライフサイエンスコーパス: increased mortality

1 eased mortality, no change in mortality, and increased mortality).

2 ltrafiltration rate has been associated with increased mortality.

3 hom, there was a significant interaction for increased mortality.

4 alizations is a marker of poor prognosis and increased mortality.

5 functions, reduced bacterial clearance, and increased mortality.

6 openia is associated with poor prognosis and increased mortality.

7 was associated with age and correlated with increased mortality.

8 t concentrations as low as 2.5 mM leading to increased mortality.

9 ry arteries diseased was not associated with increased mortality.

10 s associated with a poor quality of life and increased mortality.

11 h LAS (>60) at transplant is associated with increased mortality.

12 general medical comorbid disorders, and with increased mortality.

13 igher preventable hospitalization rates have increased mortality.

14 I 1.00-1.04) were significant predictors for increased mortality.

15 g altered feeding, reduced reproduction, and increased mortality.

16 ause a delay in diagnosis is associated with increased mortality.

17 for treatment, reduced quality of life, and increased mortality.

18 em morbidity and, when suboptimally treated, increased mortality.

19 a shorter telomere length is a predictor of increased mortality.

20 admission after lobectomy is associated with increased mortality.

21 , 1.47; P-trend = 0.01) were associated with increased mortality.

22 ynthesis in platelets and is associated with increased mortality.

23 s and surgical management is associated with increased mortality.

24 ts in hosts with advanced tumors, leading to increased mortality.

25 y complication of HTx and is associated with increased mortality.

26 ement therapy initiation was associated with increased mortality.

27 emic manifestations that are associated with increased mortality.

28 onors were not significantly associated with increased mortality.

29 seeking hypertension care is associated with increased mortality.

30 diet suffer significantly reduced growth and increased mortality.

31 ses and weight loss explain only part of the increased mortality.

32 lipoprotein levels, was not associated with increased mortality.

33 treatment of drug-resistant tuberculosis and increased mortality.

34 es of liver cirrhosis lead to a dramatically increased mortality.

35 is, the resulting hyperphosphatemia leads to increased mortality.

36 pment of atrial-esophageal fistula (AEF) and increased mortality.

37 d sequential feeding of two different dsRNAs increased mortality.

38 sociated with impaired exercise capacity and increased mortality.

39 ibute to CNS viremia, neuroinflammation, and increased mortality.

40 ailed to resolve the infection, resulting in increased mortality.

41 VAs, although its use may be associated with increased mortality.

42 nd viral loads in spinal cord and testes-and increased mortality.

43 ital bypass is independently associated with increased mortality.

44 ed normal, are independently associated with increased mortality.

45 ce utilization, higher caregiver burden, and increased mortality.

46 ecline >=5% postinfection may be markers for increased mortality.

47 al burden in the brain, which was coupled to increased mortality.

48 cedural AR was independently associated with increased mortality.

49 ascular disease (CVD), diabetes, cancer, and increased mortality.

50 s associated with heart failure, stroke, and increased mortality.

51 (AKI) after major trauma is associated with increased mortality.

52 rrhythmias as a possible explanation of this increased mortality.

53 The program was not associated with increased mortality.

54 istration of IFN-alpha2b was associated with increased mortality.

55 d are associated with multiorgan failure and increased mortality.

56 metastasis were independent risk factors for increased mortality.

57 positively associated with HIV infection and increased mortality.

58 as been linked to adverse health effects and increased mortality.

59 ition (SAM) in Africa and is associated with increased mortality.

60 -flow nasal cannula use were associated with increased mortality.

61 hours after septic shock was associated with increased mortality.

62 patients have worse functional outcomes and increased mortality.

63 IRI leads to impaired recovery after AKI and increased mortality.

64 quently under recognized and associated with increased mortality.

65 n levels, was associated with decreased (not increased) mortality.

66 LUMKO mice exhibited increased mortality 1-14 days post-AB.

67 age HIV-positive status was associated with increased mortality (21.3% vs. 9.6%; p<0.001 [log-rank t

68 Those with worsening eGFR had increased mortality (25.5% vs 19.1%, P = .07) but no sig

69 negative fluid balance, was associated with increased mortality (30.3% vs 21.1% vs 22%, respectively

70 or a BDG concentration increasing >100pg/ml increased mortality (48.1%).

71 Cox regression analyses, ID associated with increased mortality (81 events; hazard ratio, 1.95; 95%

72 tor-deficient (IL-36R(-/-)) mice resulted in increased mortality, a delay in lung bacterial clearance

73 LP use was not associated with significantly increased mortality (adjusted hazard ratio 0.99, 95% con

74 mon (196, 83%), and this was associated with increased mortality (adjusted hazard ratio 1.7, 95% CI 1

75 tions remained independently associated with increased mortality (adjusted subdistribution hazard rat

76 Both TRF and TRVol were associated with increased mortality after adjustment for clinical and im

77 TAPSE <17 mm was associated with increased mortality after adjustment for established pro

78 on, greater rates of myocardial rupture, and increased mortality after chronic MI relative to WT.

79 ntricular ejection fraction in parallel with increased mortality after MI in T2DM mice compared with

80 Factors associated with increased mortality after SCA were age, heart failure, a

81 rrelates with lack of reverse remodeling and increased mortality after TAVR and improves risk predict

82 Diabetes mellitus (DM) is associated with increased mortality after transplantation, but the effec

83 larly, mice with the alpha1A KI mutation had increased mortality after transverse aortic constriction

84 versely, mice with a cDC Baff deficiency had increased mortality after WNV infection and decreased WN

85 .11 ml(-1) was independently associated with increased mortality, after adjusting for age, clinical a

86 Crystalloid volume was associated with increased mortality among patients receiving blood produ

87 is associated with poor outcomes, including increased mortality, among critically ill children and y

88 Possible negative effects, including increased mortality, among persons who receive stored re

89 RBC transfusion correlates with increased mortality and acute kidney injury early after

90 epsis, MAIT-deficient mice had significantly increased mortality and bacterial load, and reduced tiss

91 nts with ACS and is strongly associated with increased mortality and cardiovascular events.

92 istress syndrome (ARDS) were associated with increased mortality and delayed viral clearance.

93 have previously shown to be associated with increased mortality and features of immunosuppression.

94 d older and is independently associated with increased mortality and greater disability.

95 substantial bone-associated morbidities, and increased mortality and health-care costs.

96 gher baseline heart rate was associated with increased mortality and heart failure hospitalizations a

97 ble, elevated heart rate was associated with increased mortality and heart failure hospitalizations,

98 nd right atrial pressure was associated with increased mortality and higher SCAI Stage.

99 We found evidence of increased mortality and hospital admissions for circulat

100 ntubation within 30 days, is associated with increased mortality and hospital costs.

101 id treatment in influenza is associated with increased mortality and hospital-acquired infection, but

102 oexist and are independently associated with increased mortality and hospitalizations.

103 ts showed an association between digoxin and increased mortality and hospitalizations; however, other

104 immunoproteasome deficiency in neonatal mice increased mortality and impaired IFN-gamma responses in

105 ng surgery was significantly associated with increased mortality and increased complications among pa

106 less often found in favor of treatments that increased mortality and increased days free of ventilati

107 n after failed extubation is associated with increased mortality and longer hospital length of stay.

108 However, a direct link between the increased mortality and morbidity and the infant's immun

109 HCA is associated with increased mortality and morbidity in both premature and

110 Muscle wasting is associated with increased mortality and morbidity in chronic kidney dise

111 of hypervirulent strains has contributed to increased mortality and morbidity of CDI.

112 er of additional deaths, and QALYs lost from increased mortality and morbidity, all per increase of $

113 V-exposed uninfected (HEU) infant, including increased mortality and morbidity, immunological changes

114 Its expansion in obesity results in increased mortality and morbidity, with contributions to

115 2.5) concentrations has been associated with increased mortality and morbidity.

116 Patients with FM have an increased mortality and need for heart transplantation c

117 ity, conferring cardiovascular morbidity and increased mortality and often necessitating mechanical v

118 by S. aureus or P. aeruginosa, resulting in increased mortality and organ colonization.

119 e oxysterol cholestenoic acid associate with increased mortality and organ failure in septic patients

120 Despite fitness costs associated with increased mortality and significant impairment, bipolar

121 sing pulmonary consolidation and hemorrhage, increased mortality and specific modification of gut mic

122 ularly poor air quality, was associated with increased mortality and that associations vary by urbani

123 tents reported that they are associated with increased mortality and that higher doses are linked to

124 enal replacement therapy was associated with increased mortality and was also associated with lower r

125 t ductus arteriosus (PDA) is associated with increased mortality and worsened respiratory outcomes, i

126 ment therapy initiation were associated with increased mortality, and baseline thrombocytopenia was a

127 Sepsis/IM resulted in AKI, increased mortality, and in renal AMPK activation 6-24 h

128 in strain is associated with severe disease, increased mortality, and increased human-to-human transm

129 thasone treatment worsened motor impairment, increased mortality, and increased viral loads.

130 with readmission for bacteremia recurrence, increased mortality, and longer hospitalization.

131 onary artery disease was not associated with increased mortality, as has been suggested for periphera

132 n patients with heart related disorders, and increased mortality associated with COVID-19 cardiac com

133 el-based studies conflicts with the observed increased mortality associated with low sodium intake in

134 arterial blood pressure greater than 80% had increased mortality at 3 months.

135 GNB was independently associated with increased mortality at 4 months both in allo-HSCT (hazar

136 more likely to have progressive disease and increased mortality at 5 years compared with those witho

137 diabetic retinopathy and neuropathy) lead to increased mortality, blindness, kidney failure and an ov

138 eekend hospital admission is associated with increased mortality, but the contributions of varying il

139 However, theory also suggests that increased mortality can lead to no change or even increa

140 es (ICF) 4 syndrome is a severe disease with increased mortality caused by mutation in the LSH gene.

141 t those with hyperchloremic acidosis, had an increased mortality compared to patients without alterat

142 rved, but S411A Kunjin infection resulted in increased mortality compared to WT Kunjin infection.

143 his resulted in more severe inflammation and increased mortality compared with control mice.

144 Proteobacteria dominance was associated with increased mortality compared with Firmicutes-dominated o

145 Patients with IgAN have an increased mortality compared with matched controls, with

146 dney replacement therapy are associated with increased mortality compared with moderate UF(NET) rates

147 .66; 95% CI, 1.11-2.50) were associated with increased mortality compared with normoxia.

148 6% versus 5%; P < 0.001) and more than a 50% increased mortality compared with stage 1 AKI-SC (14.6%

149 6.9-13.3), and ARR was also associated with increased mortality, controlling for HIV and other varia

150 d Angiopoietin-2 levels were associated with increased mortality (died 21.9 [13.9, 30.3] ng/mL vs. al

151 in the pressure-overloaded heart, leading to increased mortality, dilatation and contractile dysfunct

152 with suspected infection is associated with increased mortality, discharge to long-term care, hospit

153 vealed that hypertension was associated with increased mortality due to all causes (HR 1.57, 95% conf

154 ears or older, higher PP was associated with increased mortality due to circulatory system diseases b

155 r, the extreme polycythemia and accompanying increased mortality due to heart failure in chronic moun

156 Moderate hyperoxia was associated with increased mortality during extracorporeal cardiopulmonar

157 HIV-infection is associated with increased mortality during multidrug-resistant tuberculo

158 ed by exacerbated inflammatory responses and increased mortality during sepsis.

159 ound patient residences were associated with increased mortality during TB treatment, although the fi

160 treatment, which may have contributed to the increased mortality during the pandemic.

161 inib was used in a front-line setting showed increased mortality during treatment compared with conve

162 ase in steady-state IL-33 levels resulted in increased mortality, enlarged alveolar spaces resembling

163 ascular disease (CVD) and is associated with increased mortality, excess disability, greater health c

164 Old mice exhibited increased mortality following both cecal ligation and pu

165 We observed increased mortality following i.v.

166 ng type I IFN receptors (Ifnar1(-/-)) showed increased mortality following infection with wild-type p

167 ular regurgitation (PVR) are associated with increased mortality following transcatheter aortic valve

168 e spent in transgression was associated with increased mortality for intracranial pressure greater th

169 servational studies consistently demonstrate increased mortality for polymyxins compared with alterna

170 Despite the increased mortality from cancer in people with mental il

171 m PM2.5 exposure is significantly related to increased mortality from respiratory disease, lung cance

172 d diabetes (HR, 0.38; 95% CI, 0.29-0.49) but increased mortality from suicide (HR, 1.68; 95% CI, 1.32

173 A suspension event was associated with increased mortality from the time of listing (adjusted H

174 A suspension event was associated with increased mortality from the time of listing (aHR: 1.79,

175 -null mice have normal blood pH, but exhibit increased mortality, growth retardation, corneal edema,

176 terval [95% CI], 0.41-0.90) and non-preKT an increased mortality hazard (HR, 1.15; 95% CI, 1.03-1.27)

177 lent of task-hours/week) was associated with increased mortality (hazard ratio (HR) = 1.50, 95% confi

178 atients, RBC transfusion was associated with increased mortality (hazard ratio, 2.07 [95% CI, 1.06-4.

179 cystatin C was near-linearly associated with increased mortality, hazard ratio equals to 1.78 (95% CI

180 Increased mortality, however, persisted, attributed to e

181 e analysis, LV GLS <7.0% was associated with increased mortality (HR: 1.337; 95% confidence interval:

182 etic scores should have been associated with increased mortality if low low-density lipoprotein level

183 vival, while AMPK inhibition with Compound C increased mortality, impaired mitochondrial respiration,

184 cumulative fluid balance are associated with increased mortality in a general population and defined

185 A-to-CST conversion was also associated with increased mortality in acute HF, thus, supporting functi

186 tosis resistance, enhanced dissemination and increased mortality in animal models.

187 Surprisingly, HFD feeding markedly increased mortality in atERalphaKO mice associated with

188 counts were associated with lower HbA1c and increased mortality in both datasets.

189 doxical LF was independently associated with increased mortality in both women (adjusted HR: 2.05; 95

190 ascular repair, persistent inflammation, and increased mortality in contrast with the wild-type litte

191 is the recommended management of shock, but increased mortality in febrile African children in the F

192 lovirus (CMV) viremia may be associated with increased mortality in HIV-infected persons with tubercu

193 Older age is associated with increased mortality in immune thrombotic thrombocytopeni

194 is associated with longer length of stay and increased mortality in kidney transplant (KT) recipients

195 come relationship in pancreatic surgery with increased mortality in low volume hospitals.

196 from female donors has been associated with increased mortality in male recipients.

197 M and/or Xpert MTB/RIF) were associated with increased mortality in multivariate analyses.

198 M and/or Xpert MTB/RIF) were associated with increased mortality in multivariate analyses.

199 This increased mortality in myeloid autophagy gene-deficient

200 Influenza viral infections often lead to increased mortality in older people.

201 Moderate hyperoxia was associated with increased mortality in patients undergoing veno-venous e

202 calis with more severe clinical outcomes and increased mortality in patients with alcoholic hepatitis

203 Higher serum ASCA was associated with increased mortality in patients with alcoholic hepatitis

204 ly goal-directed therapy was associated with increased mortality in patients with high-disease severi

205 While several studies have demonstrated increased mortality in patients with mPAP less than that

206 and invasive breast cancers as well as with increased mortality in patients.

207 This is associated with increased mortality in pediatric influenza critical illn

208 imorbidity count and reduced HbA1c alongside increased mortality in people with T2D and further exami

209 lovirus (CMV) viremia may be associated with increased mortality in persons living with HIV who have

210 test the hypothesis that fast privatisation increased mortality in Russia.

211 Anemia, which is associated with increased mortality in Salmonella-infected humans, was e

212 nsity lipoprotein levels are associated with increased mortality in sepsis.

213 identify risk factors that might explain the increased mortality in socially isolated and lonely indi

214 c control, intensive glycemic control caused increased mortality in the Action to Control Cardiovascu

215 pairs immune function and is associated with increased mortality in the elderly.

216 nazole in histoplasmosis was associated with increased mortality in the first 42 days compared to itr

217 e spent in transgression was associated with increased mortality in the full cohort for hemoglobin le

218 ence of two distinct but associated effects: increased mortality in the north region (regional effect

219 Hydrocortisone use was associated with increased mortality in those with an SRS2 phenotype (odd

220 We thus sought to identify risk factors of increased mortality in treatment-naive, AL cardiac amylo

221 ve diabetes control has been associated with increased mortality in type 2 diabetes (T2DM); this has

222 Hypoxemia was associated with an increased mortality in veno-venous extracorporeal membra

223 rdingly, a clear and consistent threshold of increased mortality (including 1- and 5-year actuarial m

224 1 year after diagnosis were associated with increased mortality independent of treatment method (HR

225 ociation between major second dose delay and increased mortality, length of stay, and mechanical vent

226 ing frost events can result in significantly increased mortality levels of H. halys adults.

227 apy have failed to prevent CVD and have even increased mortality, making clinical decision making dif

228 These data suggest that the increased mortality observed in patients with AIDS with

229 In conclusion, the increased mortality observed in the intensive glycemic c

230 ncentrations with decreased reproduction and increased mortality occurring between 5 and 40 mg Cl(-)/

231 sibly depressive symptoms (-1.14%; P = 0.05) increased mortality odds.

232 kg predicted body weight was associated with increased mortality (odds ratio, 1.82; 95% CI, 1.20-2.78

233 A high CO2 gap was associated with increased mortality (odds ratio, 2.22; 95% CI, 1.30-3.82

234 cells in the lungs remained largely intact, increased mortality of SAP-deficient mice correlated wit

235 dity score was independently associated with increased mortality (P = 0.003; odds ratio, 1.254; 95% c

236 hest tube were independently associated with increased mortality (per mL/kg/extracorporeal membrane o

237 SMI patients with CAC >100 had an increased mortality rate (hazard ratio, 3.16; 95% CI, 1.

238 glycocalyx damage marker) in plasma have an increased mortality rate compared with patients with low

239 , the reduced somatic state indicated by the increased mortality rate would result in lower reproduct

240 methicillin-susceptible S. aureus pneumonia (increased mortality rate).

241 urea nitrogen, and creatinine, as well as an increased mortality rate, consistent with the developmen

242 nt prematurely halted vaccine trial revealed increased mortality rates among vaccine recipients in wh

243 with transient oliguria (AKI-UO stage 1) had increased mortality rates compared with patients without

244 Increased mortality rates from infectious diseases is a

245 and neurodegenerative diseases and predicts increased mortality rates in healthy individuals.

246 tertile (</=100 mmol/L) was associated with increased mortality rates in the context of lower sodium

247 Chronic ethanol consumption induced increased mortality rates, higher Aspergillus fumigatus

248 eGFR < 60 mL/min, which was associated with increased mortality rates, particularly within the first

249 ighly prevalent CH we detect associates with increased mortality rates, risk for hematological malign

250 This increased mortality reflects the burden of comorbidity a

251 Burn survivors had increased mortality related to trauma (mortality rate ra

252 ssociated with poor quality of life, sharply increased mortality, repeated hospitalizations, falls, a

253 Preferred recipients had no increased mortality risk (hazard ratio [HR]: 0.921.041.1

254 Preferred recipients had no increased mortality risk (hazard ratio [HR]: 0.921.041.1

255 onversely, nonpreferred recipients had a 41% increased mortality risk (HR: 1.171.411.70, p<0.001) and

256 onversely, nonpreferred recipients had a 41% increased mortality risk (HR: 1.171.411.70; P < 0.001) a

257 MUAC >= 11.5 and < 12.5 were associated with increased mortality risk (HR: 3.33, 95% CI 1.23-8.99, p

258 Each day of delay increased mortality risk 5 to 6%.

259 Concurrent benzodiazepine prescription also increased mortality risk after consideration of duration

260 tudies in the United States have reported an increased mortality risk among individuals with NAFLD, b

261 tudies in the United States have reported an increased mortality risk among individuals with NAFLD; t

262 ntrolled trials, identified an absolute 4.6% increased mortality risk associated with PTXD use.

263 2 phenotype but not in Hp1 carriers, who had increased mortality risk from intensive therapy.

264 patients presenting to ETUs and conferred an increased mortality risk in patients infected with Ebola

265 Venous thromboembolism is associated with increased mortality risk in some populations, but how fr

266 ysterectomy or myomectomy is associated with increased mortality risk in women with occult uterine ca

267 se effect on DRP, and for gabapentinoids the increased mortality risk was not specific to DRP.

268 Survival curves suggest that increased mortality risk with two 148M alleles was great

269 Intakes >20E% were associated with a 30% increased mortality risk, but increased risks were also

270 ne-fifth of cases, and is associated with an increased mortality risk, especially for VLST.

271 Children with HIV have an increased mortality risk, even when receiving tuberculos

272 ents with RAAS inhibitor-induced WRF have an increased mortality risk, without experiencing improved

273 at a high sugar intake is associated with an increased mortality risk.

274 and higher meat intake were associated with increased mortality risk.

275 days or within the first week independently increased mortality risk.

276 Repeated HFHs further increased mortality risk.

277 among nonfrail recipients may be a marker of increased mortality risk.

278 th a preformed HLA DSA is associated with an increased mortality risk.

279 an increase in heart rate is associated with increased mortality risk.

280 lin concentrations have been associated with increased mortality risk.

281 female gender, co-morbidities and confusion increased mortality risk.

282 It may also be related to an increased mortality risk.

283 d with a small but statistically significant increased mortality risk.

284 n dioxide exposures were all associated with increased mortality risk.

285 statistically significant associations with increased mortality risk: multivariable-adjusted HR (95%

286 and gabapentinoids was also associated with increased mortality risk; however, for z-drugs there was

287 Increased mortality risks were associated with low and h

288 mice with WT bone marrow were protected from increased mortality seen in chimeric WT mice with FABP4(

289 Increased IL-27 levels were consistent with increased mortality that was improved in IL-27 receptor

290 both mice and rats lacking BACE1 have shown increased mortality, the increase was smaller and restri

291 esterase inhibitor TPP resulted in markedly increased mortality (to ~80%), suggesting a role of meta

292 Ultimately, C starvation may lead to increased mortality vulnerability, but hydraulic failure

293 eated patients younger than 60 years of age, increased mortality was observed in those with lower and

294 Increased mortality was observed with a arterial carbon

295 However, increased mortality was seen in the venetoclax group, mo

296 exhibited decreased bacterial clearance and increased mortality when challenged intranasally with P.

297 16; 95% CI: 1.48, 3.16) were associated with increased mortality, whereas child age and sex were not.

298 d disrupted liver granuloma architecture and increased mortality, which indicates that failure to con

299 n HLH-30-dependent manner, also demonstrated increased mortality with starvation-refeeding that was p

300 The increased mortality with TAC was associated with increas